ZHBIO(SZ:300653) Sou Hu Cai Jing·2025-07-25 09:45Group 1 - The core viewpoint of the articles highlights the performance and valuation of Zhenghai Biological, which has a current PE ratio of 33.40, significantly lower than the industry average of 55.41 [1][2] - Zhenghai Biological's market capitalization stands at 4.037 billion yuan, with a total of 16,966 shareholders as of March 31, 2025, indicating a slight decrease in shareholder numbers [1] - The company specializes in the research, production, and sales of bio-regenerative materials, with key products including oral repair membranes and absorbable dura mater patches [1] Group 2 - The latest financial report for the first quarter of 2025 shows that Zhenghai Biological achieved a revenue of 97.42 million yuan, representing an 8.68% year-on-year increase, while net profit decreased by 34.06% to 26.63 million yuan [1] - The gross profit margin for the company is reported at 80.96%, indicating strong profitability despite the decline in net profit [1] - Zhenghai Biological has been recognized as one of the top 50 new material leading enterprises in Shandong Province for 2023, reflecting its industry standing and innovation capabilities [1]